Literature DB >> 17190945

Herbicide exposure modifies GSTP1 haplotype association to Parkinson onset age: the GenePD Study.

J B Wilk1, J E Tobin, O Suchowersky, H A Shill, C Klein, G F Wooten, M F Lew, M H Mark, M Guttman, R L Watts, C Singer, J H Growdon, J C Latourelle, M H Saint-Hilaire, A L DeStefano, R Prakash, S Williamson, C J Berg, M Sun, S Goldwurm, G Pezzoli, B A Racette, J S Perlmutter, A Parsian, K B Baker, M L Giroux, I Litvan, P P Pramstaller, G Nicholson, D J Burn, P F Chinnery, P Vieregge, J T Slevin, F Cambi, M E MacDonald, J F Gusella, R H Myers, L I Golbe.   

Abstract

BACKGROUND: Polymorphisms in the glutathione S-transferase pi gene (GSTP1), encoding GSTP1-1, a detoxification enzyme, may increase the risk of Parkinson disease (PD) with exposure to pesticides. Using the GenePD Study sample of familial PD cases, we explored whether GSTP1 polymorphisms were associated with the age at onset of PD symptoms and whether that relation was modified by exposure to herbicides.
METHODS: Seven single-nucleotide polymorphisms (SNPs) were genotyped and tested for association with PD onset age in men in three strata: no exposure to herbicides, residential exposure to herbicides, and occupational exposure to herbicides. Haplotypes were similarly evaluated in stratified analyses.
RESULTS: Three SNPs were associated with PD onset age in the group of men occupationally exposed to herbicides. Three additional SNPs had significant trends for the association of PD onset age across the herbicide exposure groups. Haplotype results also provided evidence that the relation between GSTP1 and onset age is modified by herbicide exposure. One haplotype was associated with an approximately 8-years-earlier onset in the occupationally exposed group and a 2.8-years-later onset in the nonexposed group.
CONCLUSIONS: Herbicide exposure may be an effect modifier of the relation between glutathione S-transferase pi gene polymorphisms and onset age in familial PD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17190945     DOI: 10.1212/01.wnl.0000249149.22407.d1

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  12 in total

Review 1.  Thiol-redox signaling, dopaminergic cell death, and Parkinson's disease.

Authors:  Aracely Garcia-Garcia; Laura Zavala-Flores; Humberto Rodriguez-Rocha; Rodrigo Franco
Journal:  Antioxid Redox Signal       Date:  2012-05-03       Impact factor: 8.401

2.  DJ-1 deficiency in astrocytes selectively enhances mitochondrial Complex I inhibitor-induced neurotoxicity.

Authors:  Steven J Mullett; David A Hinkle
Journal:  J Neurochem       Date:  2011-01-28       Impact factor: 5.372

3.  Nonsynonymous polymorphisms of histamine-metabolising enzymes in patients with Parkinson's disease.

Authors:  José A G Agúndez; Antonio Luengo; Oscar Herráez; Carmen Martínez; Hortensia Alonso-Navarro; Félix Javier Jiménez-Jiménez; Elena García-Martín
Journal:  Neuromolecular Med       Date:  2007-11-06       Impact factor: 3.843

4.  MDR1 variants and risk of Parkinson disease. Association with pesticide exposure?

Authors:  Katja Zschiedrich; Inke R König; Norbert Brüggemann; Norman Kock; Meike Kasten; Klaus L Leenders; Vladimir Kostić; Peter Vieregge; Andreas Ziegler; Christine Klein; Katja Lohmann
Journal:  J Neurol       Date:  2009-01-29       Impact factor: 4.849

5.  Identification of glutathione S-transferase pi as a protein involved in Parkinson disease progression.

Authors:  Min Shi; Joshua Bradner; Theo K Bammler; David L Eaton; Jianpeng Zhang; ZuCheng Ye; Angela M Wilson; Thomas J Montine; Catherine Pan; Jing Zhang
Journal:  Am J Pathol       Date:  2009-06-04       Impact factor: 4.307

6.  Genetic modification of the association of paraquat and Parkinson's disease.

Authors:  Samuel M Goldman; Freya Kamel; G Webster Ross; Grace S Bhudhikanok; Jane A Hoppin; Monica Korell; Connie Marras; Cheryl Meng; David M Umbach; Meike Kasten; Anabel R Chade; Kathleen Comyns; Marie B Richards; Dale P Sandler; Aaron Blair; J William Langston; Caroline M Tanner
Journal:  Mov Disord       Date:  2012-10-08       Impact factor: 10.338

7.  The Nrf2/SKN-1-dependent glutathione S-transferase π homologue GST-1 inhibits dopamine neuron degeneration in a Caenorhabditis elegans model of manganism.

Authors:  Raja Settivari; Natalia VanDuyn; Jennifer LeVora; Richard Nass
Journal:  Neurotoxicology       Date:  2013-05-27       Impact factor: 4.294

Review 8.  Glutathione metabolism and Parkinson's disease.

Authors:  Michelle Smeyne; Richard Jay Smeyne
Journal:  Free Radic Biol Med       Date:  2013-05-08       Impact factor: 7.376

9.  Younger age at onset of sporadic Parkinson's disease among subjects occupationally exposed to metals and pesticides.

Authors:  Marcia H Ratner; David H Farb; Josef Ozer; Robert G Feldman; Raymon Durso
Journal:  Interdiscip Toxicol       Date:  2014-12-30

10.  In vitro inhibition of glutathione-S-transferase by dopamine and its metabolites, 3,4-dihydroxyphenylacetaldehyde and 3,4-dihydroxyphenylacetic acid.

Authors:  Rachel A Crawford; Kate R Bowman; Brianna S Cagle; Jonathan A Doorn
Journal:  Neurotoxicology       Date:  2021-07-24       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.